Major players in the smart pills market are Medtronic Plc., Olympus Medical Technology, CapsoVision, Inc., Novartis AG, Proteus Pharmaceuticals, Philips Healthcare, Microchips, Bio-Images Drug Delivery (BDD) Limited, Given Imaging, Inc., and Vitality.
The global smart pills market is expected to grow from $4.03 billion in 2021 to $4.48 billion in 2022 at a compound annual growth rate (CAGR) of 11.2%. The market is expected to grow to $6.83 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%.
The smart pills market consists of the sales capsule-sized ingestible medical devices with small embedded electronic products such as sensors, cameras, patches, and trackers. Once swallowed, the smart pill gets activated in the gut and the sensors provide information about the patient’s health parameters and the effectiveness of medication leading to more optimized therapies.
The main applications of smart pills are capsule endoscopy, patient monitoring, and drug delivery, patient monitoring involves the repeated or continuous observations or measurements of the patient parameters.These pills are used to target the esophagus, stomach, small intestine, and large intestine to treat diseases such as esophageal diseases, colon diseases, small bowel diseases, and others.
Smart pills are used by various end-users such as hospitals, diagnostic centers, and research institutes.
North America was the largest region in the smart pills market in 2021.Western Europe was the second-largest region in the smart pills market.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The growing preference for non-invasive procedures is driving the smart pills market.The non-invasive procedures are diagnostic and treatment procedures that do not require an incision on the body or removal of tissues for the treatment or diagnosis.
Smart pill is a wireless, ingestible capsule that can be easily swallowed and has a wide range of applications in capsule endoscopy, drug delivery, and patient monitoring.For instance, smart pills have key applications in diagnostic imaging such as capsule endoscopy.
The capsule endoscopy is a diagnostic procedure in which a smart pill (capsule enclosed micro-camera) is swallowed and images of the esophagus, stomach, and small intestine can be taken as the device pass through your gastrointestinal (GI) tract.Smart pills have revolutionized the diagnosis of gastrointestinal disorders and could replace conventional diagnostic techniques such as endoscopy.
Therefore, non-invasive procedures are driving the smart pills market during the period.
The high cost of smart pills associated with technological advancement will act as a restraint to the market growth.The utilization of advanced technologies including software up-gradation and innovative systems, and the integration of microchips contribute to the high manufacturing costs of the smart pills.
Smart pills are a combination of drug and device technology.A smart pill is an innovative method of drug delivery, which involves the use of sensors and cameras embedded into tiny edible devices.
Such medical devices ensure better diagnostics, monitoring, and treatment of life-threatening medical conditions by allowing doctors to monitor their patients’ body functions in real-time.However, the high cost of smart pills led to the limited utilization of products in underdeveloped countries.
Thus, the high cost is considered as one of the factors that restrain the growth of the small pills market.
Extensive research and development are being carried out on the use of miniature chips such as Addressable Transmitters Operated as Magnetic Spins (ATOMS) which can be used as smart pills.ATOMS are silicon chip devices that use the principle of magnetic resonance imaging (MRI) to determine the location of atoms in a patient’s body using magnetic fields.
ATOMS can be used in ingestible smart pills to diagnose and treat diseases from within the body.The devices can be used to monitor a patient’s gastrointestinal tract, blood, or brain.
They also could measure factors that indicate the health of a patient such as pH, temperature, pressure, and sugar concentrations, and relay that information to doctors.The devices could even be instructed to release drugs.
For instance, scientists at Caltech (California Institute of Technology) have developed a miniature medical chip that can be used as a smart pill.
The countries covered in the smart pills market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• May 2022
Major players in the antimicrobial medical device coatings market are AST Products Inc, BioInteractions LTD, Covalon Technologies LTD, Royal DSM, Hydromer, BASF SE, Sciessent LLC, DuPont de Nemours Inc, Kraton Corporation, and Sono-Tek Corporation. The global antimicrobial medical device market is expected to grow from $1.77 billion...
400 pages •
By The Business Research Company
• May 2022
Major players in the microbiology diagnostics devices and equipment market are Becton Dickinnson and Company, Biomerieux, Danaher, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories Inc., Bruker Corporation, Neogen Corporation, Merck KGaA, and Charles River Laboratories International Inc. The global microbiology diagnostic...
250 pages •
By The Business Research Company
• May 2022
Major players in the wearable medical devices market are Philips, Polar Electro, Omron Corporation, Fitbit Inc., Garmin Ltd., LifeWatch AG (BioTelemetry Inc.), Xiaomi Inc., VitalConnect, Jawbone Inc., General Electric Co., and Medtronic PLC, The global wearable medical devices market is expected to grow from $18.41 billion in 2021 to...
The global holographic display market reached a value of US$ 1,350 Million in 2021. Looking forward, the analyst expects the market to reach US$ 5,130 Million by 2027, exhibiting a CAGR of 25.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Adhesives And Sealants Market 2022-2026 The analyst has been monitoring the adhesives and sealants market and it is poised to grow by $ 14.49 bn during 2022-2026, accelerating at a CAGR of 4.46% during the forecast period. Our report on the adhesives and sealants market provides a holistic analysis, market size and...
The global smart pills market reached a value of US$ 3.9 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 6.3 Billion by 2027, exhibiting at a CAGR of 7.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of...
The global analog-to-digital converters market reached a value of US$ 2.38 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 3.33 Billion by 2027, exhibiting a CAGR of 5.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period. The growth of this market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations...
As the healthcare sector adapts to the changes induced by the COVID-19 pandemic, the global medical devices industry is undergoing a major transformation in terms of business models, technology adoption, and care delivery approaches, among other areas. 2022 will prove to be another challenging year for medtech as uncertainties pertaining to...
Report Highlights: - The global contract manufacturing of medical devices market should reach $108.6 billion by 2025 from $68.0 billion in 2020 at a compound annual growth rate (CAGR) of 9.8% for the forecast period of 2020 to 2025. - The global oncology diagnostics market should reach $128.3 billion by 2025...
Healthcare
Medical Device
World
United States
Medical Devices Sales
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.